Seth H. Blum

Dopamine D2 receptor Taq A1 allele predicts treatment compliance of LG839 in a subset analysis of pilot study in the Netherlands

Kenneth Blum, Thomas J.H. Chen, Amanda LC Chen et al. · 2008 · 81 citations

Medicine, Pharmacology, Psychiatry +15

Genotrim™, a DNA-customized nutrigenomic product, targets genetic factors of obesity: Hypothesizing a dopamine–glucose correlation demonstrating reward deficiency syndrome (RDS)

Kenneth Blum, Thomas J.H. Chen, Brian Meshkin et al. · Medical Hypotheses · 2006 · 78 citations

Life Sciences, Biotechnology, Genetics +12

Nutrigenomic targeting of carbohydrate craving behavior: Can we manage obesity and aberrant craving behaviors with neurochemical pathway manipulation by Immunological Compatible Substances (nutrients) using a Genetic Positioning System (GPS) Map?

Bernard W. Downs, Amanda LC Chen, Thomas J.H. Chen et al. · Medical Hypotheses · 2009 · 68 citations

Life Sciences, Nutrition, Nutritional Sciences +17

Reward deficiency syndrome in obesity: A preliminary cross-sectional trial with a genotrim variant

Kenneth Blum, Thomas J.H. Chen, Brian Meshkin et al. · Advances in Therapy · 2006 · 58 citations

Medicine, Endocrinology, Genetics +12

LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome

Kenneth Blum, Amanda LC Chen, Thomas J.H. Chen et al. · Advances in Therapy · 2008 · 54 citations

Life Sciences, Genetics, Molecular Genetics +11